Medical Analysis

Understanding Creatine Phosphokinase (CPK) and Its Diagnostic Importance

 Creatine phosphokinase (CPK), also known as creatine kinase (CK), is a crucial enzyme protein primarily found in the brain, heart, and skeletal muscles [1]. Under normal physiological conditions, this enzyme remains within the cells; however, when muscle tissue suffers damage, the CPK enzyme leaks into the bloodstream, serving as a biological marker for injury [1, 4]. Enzymes function by catalyzing biochemical reactions, specifically facilitating the conversion of creatine to phosphocreatine [3]. To pinpoint the exact origin of damaged tissue, clinicians examine CPK isoenzymes, which are comprised of three distinct types of substances: CPK-1 (also called CPK-BB), which is mostly found in the brain and lungs; CPK-2 (also called CPK-MB), which is mostly found in the heart; and CPK-3 (also called CPK-MM), which is primarily found in skeletal muscle [1, 4].

The Creatine Kinase (CK) shuttle hypothesis illustrates how this enzyme is essential for energy metabolism [3]. In this process, ATP is created in the mitochondria, and the reverse CK reaction transfers the phosphoryl group to creatine (Cr) to produce phosphocreatine (PCr) [3]. PCr then diffuses to the myofibrils, where it is converted back to ATP via the forward CK reaction to power muscle contraction [3]. Consequently, this mechanism is vital for producing energy in muscles, transporting intracellular energy from the mitochondria to the myofibrils, facilitating muscle contraction, maintaining the normal functioning of the heart, and serving as the primary energy reserve for the heart [3].

Pathophysiology and Clinical Significance of CPK Levels

Creatine phosphokinase (CPK) acts as a central controller of cellular energy homeostasis [3]. Elevated levels of CPK generally indicate damage to cardiac (heart) muscle, skeletal muscles, or brain injury [1, 4]. Deranged CPK levels may be observed in various conditions, including rhabdomyolysis, heart disease, kidney disease, and as a side effect of certain drugs [1, 7, 9].

CPK testing is utilized for multiple clinical objectives:

• To diagnose a heart attack: Levels rise within 4–6 hours after infarction, reach a peak at 18–24 hours, and decline back to normal within 48–72 hours [1, 2]. It is worth noting that in modern medical practice, Troponin is considered more specific for this purpose [8].

• To evaluate the cause of chest pain [1].

• To detect dermatomyositis, polymyositis, and other muscle diseases [4].

• To identify malignant hyperthermia and postoperative infection [1].

• To assess muscle injury caused by trauma, muscular dystrophy, or inflammatory myopathy [1, 4].

• To monitor statin therapy, where the possibility of muscle damage is a primary concern [9].

• To evaluate rhabdomyolysis [7].

• To investigate neuromuscular disorders, such as Guillain-Barre Syndrome [1].

Various laboratory methods are employed to measure CPK, including the enzymatic method, Enzyme-linked Immunosorbent Immunoassay (ELISA), Chemiluminescent immunoassay (CLIA), and Point of care testing via rapid kit CPK methods [1]. Additionally, electrophoresis is typically used to differentiate between CPK-MM (skeletal muscle), CPK-MB (cardiac muscle), and CPK-BB (brain tissue) [4].

Patient Preparation and Sample Collection Protocols

There are no special preparations required for a patient undergoing a CPK test [1]. The procedure involves collecting 3.0 ml of blood sample in a plain tube (typically with a red cap) [1]. Once collected, it is essential to separate the serum sample as early as possible and send it to the laboratory for analysis [1].

Normal Reference Ranges and Diagnostic Calculations

The following table provides the normal reference ranges for CPK based on age and sex [1].

The CK-MB Relative Index (RI) is a calculation used to help distinguish whether an elevation in CK-MB is due to damage to the heart muscle (myocardium) or severe injury to the skeletal muscle [1]. The formula is: CK-MB Relative Index (RI) = Total CK (B) / CK-MB Mass (A) × 100.

The interpretation of the resulting RI value is summarized in the table below [1].

Various conditions can lead to elevated CPK, including brain injury, brain cancer, heart attack, pulmonary infarction, seizures, convulsions, high muscle mass, electric shock, myocarditis, muscular dystrophies, myopathy, rhabdomyolysis, and trauma [1, 7]. Conversely, decreased CPK levels may be caused by low muscle mass, severe dermatomyositis or polymyositis, alcoholic liver disease, early pregnancy (up to 20 weeks), and rheumatoid arthritis [1, 6].

For Non-Medicos: Understanding CPK Simply

For those without a medical background, it is helpful to think of Creatine Phosphokinase (CPK) as a “battery indicator” for your muscles and brain [1]. It is an enzyme found inside these tissues that helps create the energy required for them to function, such as when your heart beats or your muscles move [3].

Why is this test performed?

When your muscle or brain cells are damaged, this enzyme “leaks” out of the cells and into your bloodstream, much like how oil leaks from a damaged engine [1]. Doctors test your blood to see how much of this enzyme is present; higher-than-normal levels act as an alarm, signaling that your muscles, heart, or brain may have been injured [1].

Understanding the Isoenzymes

Because CPK is found in different parts of your body, doctors use “isoenzymes”—different types of the same protein—to figure out exactly where the damage is coming from [1].

• Total CK: This is the overall measurement and is a sensitive, yet non-specific, indicator of general muscle injury or stress [1].

• CK-MM (CK-3): This makes up 98% of the enzyme in your skeletal muscles [1]. High levels usually point to skeletal muscle damage, such as from intense exercise, injuries, or muscle diseases [1, 7].

• CK-MB (CK-2): Found mostly in heart muscle [1]. Historically, this was the key marker for heart attacks, though doctors now often use other tests like Troponin for better accuracy [2, 8].

• CK-BB (CK-1): Found primarily in the brain [1]. It is measured less frequently because it is difficult to keep stable in a blood sample [1].

Important Considerations

It is important to remember that CPK levels can be affected by your age, sex, and how much muscle mass you have [1]. For example, men often have higher baseline levels simply because they tend to have more muscle mass than women [1]. A high test result does not always mean a specific disease; it must always be reviewed by your doctor alongside your other symptoms and test results before reaching a conclusion [1].

Summary of CK Isoenzymes [1]

References:

1. Aujla, R. S. (n.d.). Creatine Phosphokinase. StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK546624/
2. Apple, F. S., Voss, E., Lund, L., Preese, L., Berger, C. R., & Henry, T. D. (1995). Cardiac troponin, CK-MB and myoglobin for the early detection of acute myocardial infarction and monitoring of reperfusion following thrombolytic therapy. Clinica Chimica Acta, 237(1-2), 59-66. https://doi.org/10.1016/0009-8981(95)06064-k Cited by: 65
3. Brewster, L. M. (2018). Creatine kinase, energy reserve, and hypertension: from bench to bedside. Annals of Translational Medicine, 6(15), 292. https://doi.org/10.21037/atm.2018.07.15 Cited by: 57
4. Cabaniss, C. D. (n.d.). Creatine Kinase. Clinical Methods: The History, Physical, and Laboratory Examinations. https://www.ncbi.nlm.nih.gov/books/NBK352/ Cited by: 101
5. Deuster, P. (2020). Clinical Practice Guideline for the Management of Exertional Rhabdomyolysis in Warfighters. Consortium for Health and Military Performance (CHAMP). https://champ.usuhs.edu/sites/default/files/2020-11/hprc_whec_clinical_practice_guideline_for_managing_er.pdf
6. Ghahiri, A. (n.d.). Assessment of The Diagnostic Capability of Serum Creatine Phosphokinase and Its Isoenzyme in Ectopic Pregnancy. PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC3850308/ Cited by: 3
7. Rout, P. (n.d.). Rhabdomyolysis. StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK448168/ Cited by: 19
8. Saenger, A. K. (n.d.). Requiem for a Heavyweight. Circulation. https://www.ahajournals.org/doi/10.1161/circulationaha.108.773218 Cited by: 154
9. Zhang, H., & To, K. K. W. (2024). Serum creatine kinase elevation following tyrosine kinase inhibitor treatment in cancer patients: Symptoms, mechanism, and clinical management. Clinical and Translational Science, 17(10), e70053. https://doi.org/10.1111/cts.70053 Cited by: 14

FAQ’s:

• What is CPK?
  CPK is an enzyme found in the brain, heart, and skeletal muscles that aids energy production.

• Why does CPK leak?
  CPK leaks into the bloodstream when muscle tissue or specific organ cells are damaged.

• What does high CPK indicate?
  Elevated CPK levels indicate damage to cardiac muscle, skeletal muscle, or potential brain injury.

• Is CPK used for hearts?
  Historically used for heart attacks, CPK is now often supplemented or replaced by more specific Troponin tests.

• What are CPK isoenzymes?
  They are three distinct forms—CPK-1, CPK-2, and CPK-3—helping identify the specific source of tissue damage.

• How is CPK measured?
  It is measured through enzymatic methods, ELISA, CLIA, rapid point-of-care kits, or laboratory-based electrophoresis.

• Does CPK require preparation?
  No, there are no special preparation requirements for patients undergoing a CPK blood test.

• What is CK-MB Index?
  It is a formula used to distinguish between heart (myocardium) and skeletal muscle damage.

• Can sex affect CPK levels?
  Yes, males generally have higher CPK levels than females due to having larger muscle mass.

• What causes low CPK?
  Low levels can result from low muscle mass, alcoholic liver disease, or early pregnancy.

Related Diagnostic Tests

• Troponin I and T

• Myoglobin

• Lactate Dehydrogenase (LDH)

• Aldolase

• Aspartate Aminotransferase (AST)